-
DMD Patients in U.S. to Get Viltolarsen Under Expanded Access Program
NS Pharma launched an expanded access program in the U.S. to allow certain Duchenne patients to gain access to viltolarsen. Click here to learn more about it.
What do you think of this plan?
Sorry, there were no replies found.
Log in to reply.